Browse Items (1 total)

BACKGROUND. The short elimination half-life of hydromorphone necessitates 4-hourly dosing to maintain optimal levels of analgesia in patients with chronic cancer pain. The purpose of this study was to compare the clinical efficacy and safety of…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2